MPM Bioventures 2018 (b), L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 97,744 shares at $34.68 ($3.3M) on 2021-12-03, disclosed to the SEC on 2021-12-07.
Open-market sale of $3.3M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.68 | 17,569 | $609K | 18.5% |
| 2 | $34.68 | 17,569 | $609K | 18.5% |
| 3 | $35.44 | 2,419 | $86K | 2.6% |
| 4 | $35.44 | 2,419 | $86K | 2.6% |
| 5 | $36.26 | 179 | $6K | 0.2% |
| 6 | $32.35 | 8,469 |
| $274K |
| 8.3% |
| 7 | $32.35 | 8,469 | $274K | 8.3% |
| 8 | $33.57 | 1,171 | $39K | 1.2% |
| 9 | $34.08 | 508 | $17K | 0.5% |
| 10 | $35.04 | 60 | $2K | 0.1% |
| 11 | $33.15 | 17,962 | $595K | 18.1% |
| 12 | $33.15 | 17,962 | $595K | 18.1% |
| 13 | $34.11 | 1,494 | $51K | 1.5% |
| 14 | $34.11 | 1,494 | $51K | 1.5% |
| Total | $33.72 avg | 97,744 | $3.3M | 100% |
| Filing → |
| ITOS | SELL | 2021-09-08 | $2.4M | — | Filing → |